GSK Biological Pandemic Candidate Influenza Vaccine (H1N1)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK Biological Pandemic Candidate Influenza Vaccine (H1N1), covering 2017-05-04 to 2017-05-04. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of GSK Biological Pandemic Candidate Influenza Vaccine (H1N1) in Children [Phase 3]